R Squared LTD Amylyx Pharmaceuticals, Inc. Transaction History
R Squared LTD
- $93.6 Billion
- Q1 2025
A detailed history of R Squared LTD transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, R Squared LTD holds 12,736 shares of AMLX stock, worth $65,208. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,736
Previous 6,370
99.94%
Holding current value
$65,208
Previous $24.1 Million
87.24%
% of portfolio
0.05%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AMLX
# of Institutions
150Shares Held
72.6MCall Options Held
148KPut Options Held
98.7K-
Perceptive Advisors LLC New York, NY7.87MShares$40.3 Million1.17% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$30.4 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$29.2 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$21.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.08MShares$15.8 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $300M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...